Open Access

Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Event: ESC CONGRESS 2017
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
Sponsored by Bayer AG
Date: 28 August 2017
Time: 12:45 - 13:45

Session

5 presentations in this session

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Professor R. Mehran (New York, US)
Thumbnail

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Speaker: Professor K. Fox (Edinburgh, GB)
Thumbnail

Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

How can we appropriately treat multimorbid patients with AF?

Speaker: Doctor C. Ruff (Boston, US)
Thumbnail

Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Doctor R. Cappato (Milan, IT)
Thumbnail

5 speakers from this session

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
28 presentations
1 follower

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
35 presentations
0 follower

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Doctor Christian Ruff

Brigham and Women's Hospital, Boston (United States of America)
20 presentations
0 follower

Doctor Riccardo Cappato

Humanitas Research Hospital, Milan (Italy)
12 presentations
0 follower

This platform is supported by

logo Novo Nordisk